OpenBilldrug price receipt

NADAC week of 2026-10-14

TRANYLCYPROMINE SULF 10 MG TAB

For 30 tablets

Pharmacies pay

$17.73 filed

30 × $0.5911 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$31.55 filed

30 × $1.05179 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.8× estimated

Medicare paid 1.8× what pharmacies pay.

Part D averages every strength and form sold under “Tranylcypromine Sulfate” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$25.39 estimated

$17.73 + $2.66 (15%) + $5.00 fee per fill = $25.39

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

TRANYLCYPROMINE SULF 10 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “tranylcypromine” and “tranylcypromine sulfate”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 4 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., Solco Healthcare US, LLC and Strides Pharma Science Limited.

FDA’s Established Pharmacologic Class for it is Monoamine Oxidase Inhibitor.

The NADAC file of 2026-10-14 prices it under 4 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $17.73 for 30 tablets (30 × $0.5911 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

All 4 NDCs

Compared with its class

The middle of its 4 NDCs’ NADAC prices is $0.5911 per EA filed.

Of the 9 other products in FDA’s Monoamine Oxidase Inhibitor class priced per EA, 7 have a higher middle NADAC price and 2 a lower one. The one in the middle is RASAGILINE MESYLATE 1 MG TAB, at $0.92551 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $31.55 for 30 tablets, at an average of $1.05179 per EA in 2024 (2024-01-01 to 2024-12-31) for “Tranylcypromine Sulfate”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 11,298 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for TRANYLCYPROMINE SULF 10 MG TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Tranylcypromine Sulfate / Tranylcypromine Sulfate: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.